AstraZeneca halts coronavirus vaccine trial after volunteer develops ‘unexpected’ illness



In a significant development, pharmaceutical company AstraZeneca on Tuesday (September 8) said that it “voluntarily paused” the phase 3 clinical human trials of its vaccine candidate ‘Covishield’ after one of the volunteers got ill. It is to be noted that AstraZeneca is developing this vaccine in collaboration with University of Oxford.